Comparative evaluation of oncologic outcomes in colon cancer
AUTOR(ES)
Bernardes, Mário Vinícius Angelete Alvarez, Feitosa, Marley Ribeiro, Peria, Fernanda Maris, Tirapelli, Daniela Pretti da Cunha, Rocha, José Joaquim Ribeiro da, Feres, Omar
FONTE
Acta Cir. Bras.
DATA DE PUBLICAÇÃO
2016
RESUMO
PURPOSE: In this paper we report clinical variables on colon cancer series. Oncological outcomes were compared to low-income and high-income countries. METHODS: We analysed a prospective database of 51 colon cancer patients submitted to primary tumor resection between 2010 and 2011, showing clinical variables and oncologic outcomes. RESULTS: R0 resection obtained in 80.4%, 21.6% of patients was TNM stage IV, and only 13.7% showed TNM stage I. Disease-free survival was 32 months, overall survival was 46 months, and the tumoral recurrence rate was 9.8%. Univariate analysis showed association of serum CEA levels ≥ 5 ng/dl (p= 0.004), presence of metastasis at diagnosis (p= 0.012), compromised surgical margins (p < 0.001) and poorer tumor differentiation (p= 0.041) to death. Multivariate analysis identified compromised surgical margins as an independent risk factor for death due to colon cancer (P=0.003; odds ratio=0.36; 95% confidence interval=0.004-0.33). Nowadays, 62.7% of patients are alive. CONCLUSION: Recurrence rate, disease-free survival and overall survival was similar to those observed in more developed countries. Serum CEA levels ≥ 5 ng/dl, the presence of metastasis at diagnosis, compromised surgical margins and poorer tumor differentiation were associated with death. A compromised surgical margin was the only independent risk factor for death.
Documentos Relacionados
- Multicentric oncologic outcomes of high-intensity focused ultrasound for localized prostate cancer in 803 patients
- Contemporary analysis of erectile, voiding, and oncologic outcomes following primary targeted cryoablation of the prostate for clinically localized prostate cancer
- Radical nephroureterectomy for pathologic T4 upper tract urothelial cancer: can oncologic outcomes be improved with multimodality therapy?
- Functional and oncologic outcomes after nephron-sparing surgery in a solitary kidney: 10 years of experience
- Anaerobic infection in cancer patients: comparative evaluation of clindamycin and cefoxitin.